A combined PSMA-PET/MRI scanner better detected clinically significant prostate cancer in men on active surveillance. The addition of piflufolastat F18 (18 F-DCFPyL) prostate-specific membrane antigen ...

Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT was superior to multiparametric MRI for primary locoregional staging of prostate cancer, according to results from a phase II ...

Dr. Gary Small answers the question: 'MRI, PET Scan for Alzheimer's Diagnosis?' May 4, 2009 -- Question: When are imaging diagnostics, such as an MRI or PET scan, used to determine whether I have ...

"Milford Regional Medical Center is a highly respected community hospital with a strong commitment to clinical excellence," said Peter Ferrari, President of Shields Health. We are proud to collaborate ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...

In a parallel randomised trial, O-(2-[18F]fluoroethyl)-L-tyrosine (FET)-PET led to comparable survival outcomes to contrast-enhanced T1-weighted (CE-T1) MRI for re-irradiation planning in patients ...